Form 4 for ACH ACCENDRA HEALTH INC/VA/
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-17 · accession 0001062993-22-012902 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-05-18 | 2022-05-17 | ACH | Pesicka Edward A | Pres, CEO, Dir | S - Sale | $35.92 | -12.0K | 1.28M | -0.9% | -$432.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-17 | S | D | 12,028 | $35.92 | 1,283,149 | D | — | — | (F1) The sale of securities reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective March 3, 2022 (F2) Weighted average of the sale price range of $35.27 through $36.20 |